Redx Pharma Future Growth
Future criteria checks 0/6
Redx Pharma's revenue and earnings are forecast to decline at 37.6% and 22.3% per annum respectively.
Key information
-22.3%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 21.5% |
Revenue growth rate | -37.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 02 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2025 | N/A | -49 | N/A | -48 | 1 |
9/30/2024 | 13 | -26 | N/A | -24 | 1 |
9/30/2023 | 4 | -33 | -35 | -35 | N/A |
6/30/2023 | 8 | -31 | -32 | -32 | N/A |
3/31/2023 | 13 | -29 | -30 | -30 | N/A |
12/31/2022 | 16 | -24 | -19 | -19 | N/A |
9/30/2022 | 19 | -18 | -9 | -8 | N/A |
6/30/2022 | 17 | -18 | -8 | -8 | N/A |
3/31/2022 | 16 | -19 | -8 | -7 | N/A |
12/31/2021 | 13 | -20 | -15 | -14 | N/A |
9/30/2021 | 10 | -22 | -22 | -21 | N/A |
6/30/2021 | 8 | -20 | -15 | -14 | N/A |
3/31/2021 | 7 | -18 | -7 | -7 | N/A |
12/31/2020 | 6 | -14 | -4 | -3 | N/A |
9/30/2020 | 6 | -9 | 0 | 0 | N/A |
6/30/2020 | 5 | -8 | -2 | -2 | N/A |
3/31/2020 | 4 | -6 | -5 | -5 | N/A |
12/31/2019 | 4 | -5 | -5 | -5 | N/A |
9/30/2019 | 3 | -4 | -5 | -5 | N/A |
6/30/2019 | 2 | -5 | -6 | -6 | N/A |
3/31/2019 | N/A | -7 | -8 | -8 | N/A |
12/31/2018 | 0 | -8 | -13 | -13 | N/A |
9/30/2018 | 0 | -9 | -17 | -17 | N/A |
6/30/2018 | 15 | -1 | -4 | -4 | N/A |
3/31/2018 | 31 | 8 | 9 | 9 | N/A |
12/31/2017 | 31 | 5 | 11 | 11 | N/A |
9/30/2017 | 30 | 2 | 14 | 14 | N/A |
6/30/2017 | 15 | -9 | N/A | -1 | N/A |
3/31/2017 | N/A | -19 | N/A | -16 | N/A |
12/31/2016 | N/A | -17 | N/A | -14 | N/A |
9/30/2016 | N/A | -16 | N/A | -13 | N/A |
6/30/2016 | N/A | -14 | N/A | -11 | N/A |
3/31/2016 | N/A | -12 | N/A | -9 | N/A |
12/31/2015 | N/A | -10 | N/A | -8 | N/A |
9/30/2015 | N/A | -8 | N/A | -7 | N/A |
6/30/2015 | N/A | -7 | N/A | -6 | N/A |
3/31/2015 | N/A | -5 | N/A | -5 | N/A |
12/31/2014 | N/A | -4 | N/A | -4 | N/A |
9/30/2014 | N/A | -3 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0RX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0RX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0RX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0RX's revenue is expected to decline over the next 3 years (-37.6% per year).
High Growth Revenue: 0RX's revenue is forecast to decline over the next 3 years (-37.6% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0RX's Return on Equity is forecast to be high in 3 years time